Abstract. The present case report was aimed at identifying the molecular profile characteristic of a primitive neuroectodermal tumor (PNET) in a 3-year-old child affected by a lesion localized in the cerebellar region. The histological diagnosis was medulloblastoma. In vivo single voxel 1 H magnetic resonance spectroscopy (MRS) shows high specificity in detecting the main metabolic alterations in the primitive cerebellar lesion; a very high amount of the choline-containing compounds and very low level of creatine derivatives and Nacetylaspartate. Ex vivo high resolution magic angle spinning (HR-MAS) 1 H magnetic resonance spectroscopy, performed at 9.4 Tesla on the neoplastic specimen collected during surgery, allows for the unambiguous identification of several metabolites giving a more in-depth evaluation of the metabolic pattern of the lesion. The ex vivo HR-MAS MR spectra show that the spectral detail is much higher than that obtained in vivo and that, for example, myo-inositol, taurine and phosphorylethanolamine contribute to the in vivo signal at 3.2 ppm, usually attributed to choline-containing compounds. In addition, the spectroscopic data appear to correlate with some morphological features of the medulloblastoma. Consequently, the present study shows that ex vivo HR-MAS 1 H MRS is able to strongly improve the clinical possibility of in vivo MRS and can be used in conjunction with in vivo spectroscopy for clinical purposes.
Introduction
In clinical examinations, in vivo magnetic resonance spectroscopy (MRS) is a non-invasive method to detect the biochemical changes accompanying the disease. The clinical impact of MRS in medicine has been widely reviewed by Smith et al and shows promise as a method to complement routine diagnostic investigation (1) . However, the poor in vivo spectral resolution leads to limited characterization of the real biochemical composition of explored tissue. Moreover, even among metabolites that are highly detectable with in vivo MRS, subtle concentration differences between normal and pathological tissue, such as a neoplasm, can go unnoticed and result in a diagnostic error.
The detailed biochemical picture of tissue is the basis of correct interpretation by in vivo MRS, which can be used when the molecular markers are well established. A deep knowledge of the biochemical composition of tissue can be obtained by spectroscopic analysis on extracts obtained from tissue (in vitro MRS) or directly from tissue specimens (ex vivo MRS). High resolution magic angle spinning (HR-MAS) ex vivo MRS is a powerful analytical tool for human tissue, potentially bridging the divide between in vitro and in vivo MRS. The first applications of HR-MAS MRS on human tissue specimens date back to 1997 (2, 3) and are possible thanks to the commercial diffusion of MRS probe-heads capable of studying samples in rapid rotation around an axis of 54.7˚ ('magic angle'), tilted with respect to that of the static magnetic field. These probe-heads drastically reduce contributions from dipolar couplings, chemical shift anisotropy and susceptibility distortions, thus providing high resolution spectra from semisolid samples such as tissue (4) (5) (6) (7) (8) (9) (10) (11) . The quality of the obtained spectra is comparable to that obtained from aqueous extracts, and the possible acquisition techniques are the same as those employed in in vitro MRS, with the advantage of carrying out measurements on intact tissue specimens without pretreatment.
We present a case where a comparison between in vivo single voxel and ex vivo HR-MAS 1 H MRS was performed on a child affected by medulloblastoma.
Case report
Clinical material. A 3-year-old child was admitted to the hospital because of persistent headaches, which started 1 month previously, and a refusal to eat due to persistent nausea. He underwent magnetic resonance imaging (MRI) and in vivo 1 H MRS of the head on a 1.5 Tesla clinical imager (Philips Intera, Best, Netherlands), which revealed an intracranial tumor occupying most of the left portion of the posterior fossa. Compared to brain parenchyma, the lesion was predominantly hyperintense on T2-weighted images and slightly hypointense on T1-weighted images with restricted apparent diffusion coefficient (ADC). After intravenous gadolinium injection, the mass was enhanced strongly, but not uniformly due to internal small cystic components (Fig. 1) . Extension to supratentorial space through the Pacchioni foramen was clearly visualized, and an extra-axial subarachnoid location was initially suggested. Compression of the fourth and third ventricles and the aqueductus caused marked hypertensive triventricular hydrocephalus. Spine imaging revealed diffused leptomeningeal tumor localizations. The very large dimension of the tumor combined with the high cellular density, as suggested by the restricted ADC, and the apparent extra-axial localization into the subarachnoid space, raised the diagnostic hypotheses of a rare case of lymphoma to be differentiated from medulloblastoma.
After MR examination, a ventricular-peritoneal shunt was positioned. Twelve days after MRI, the child underwent brain surgery, which revealed an intra-axial tumor. Extemporaneous histological examination on a sample was diagnostic for medulloblastoma and extensive, but only partial resection of the tumor was possible.
Subsequent histopathological analysis revealed apoptotic elements, necrosis, high proliferation activity (MIB1 =70%) and highly positive CD56 immunoassay. No nodular aspect was reported.
In vivo 1 H MRS. In vivo
1 H MR spectra were performed using a spin-echo sequence with 144 ms echo time (TE), 2 sec repetition time (TR), and averaging the signal of 128 consecutive scans, 512 data points and PRESS localization technique. Two volumes of interest (VOI) (3x2x2 cm) were placed respectively on the tumor mass ( Fig. 1 ) and on normalappearing cerebellar parenchyma. Water signal suppression was performed using a standard CHESS sequence with two Gaussian chemical shift selective pulses of 70 Hz. The data were processed using CSX2 (Kennedy Krieger Institute, Baltimore, USA). DC Correction, Zero Filling factor 2, Gaussian Filter with L.B. 3.0 Hz (time domain), High Pass Filter Bandwith 50 Hz (to suppress water peak) and baseline correction was applied to both the spectra data.
Ex vivo HR-MAS
1 H MRS. During neurosurgery, a sample of the medulloblastoma was put in liquid nitrogen and stored at -85˚C until ex vivo MRS analysis. Before MRS examination, Proton HR-MAS spectra were recorded with a Bruker Avance 400 spectrometer equipped with a 1 H, 13 C HR-MAS probe, utilizing the sequences implemented in the Bruker software. The sample was spun at 2800 Hz and three different types of 1D (monodimensional) proton spectra were acquired by using: i) a composite pulse sequence (zgcppr) (12) with 1.5 sec water-presaturation during relaxation delay, 8 kHz spectral width, 32k data points, 32 scans; ii) a water-suppressed spin-echo Carr-Purcell-Meiboom-Gill sequence (cpmgpr) (13) with 1.5 sec water-presaturation during relaxation delay, 1 ms echo time ( Ù) and 360 ms total spin-spin relaxation delay (2nÙ), 8 KHz spectral width, 32k data points, 256 scans; and iii) a sequence for diffusion measurements based on stimulated echo and bipolar-gradient pulses (ledbpgp2s1d) (14) with big delta 200 ms, eddy current delay Te 5 ms, little delta 2x2 ms, sine-shaped gradient with 32 G/cm followed by a 200 µs delay for gradient recovery, 8 kHz spectral width, 8k data points, 256 scans. Two-dimensional 1 H, 1 H-correlation spectroscopy (COSY) (15,16) spectra were acquired using a standard pulse sequence (cosygpprqf) and 0.5 sec waterpresaturation during relaxation delay, 8 kHz spectral width, 4k data points, 32 scans per increment, 256 increments. Two-dimensional (2D) 1 H, 1 H-total correlation spectroscopy (TOCSY), (17, 18) spectra were acquired using a standard pulse sequence (mlevphpr) and 1 sec water-presaturation during relaxation delay, 100 ms mixing (spin-lock) time, 4 kHz spectral width, 4k data points, 32 scans per increment, 128 increments. Two-dimensional 1 H, 13 C-heteronuclear single quantum coherence (HSQC) (19) were acquired using a echoantiecho phase sensitive standard pulse sequence (hsqcetgp) and 0.5 sec relaxation delay, 1.725 ms evolution time, 4 kHz spectral width in f 2 , 4k data points, 128 scans per increment, 17 kHz spectral width in f 1 , 256 increments.
Results and Discussion
The single voxel in vivo 1 H MR spectra obtained from the medulloblastoma and contralateral healthy cerebellum are reported in Fig. 2a and b , respectively. The spectrum of the lesion (Fig. 2a) displays one predominant signal at 3.2 ppm, which is usually attributed to choline-containing compounds (ChoCC); accompanied by low intensity peaks at 3.0 ppm, attributable to creatine derivatives (Cr); at 2.3 ppm, attributable to glutamate plus glutamine (Glx); and at 2.0 ppm, attributable to N-acetylaspartate (NAA) and Glx (5). The high ChoCC/Cr ratio found in the present case can be associated with the synthesis of new cell membranes. Several MRS studies correlate the increase of such compounds to the cell neoplastic proliferation (20, 21) .
Moreover, it can be noted that signals downfield from ChoCC are nearly absent in the MR spectrum of the lesion with respect to that of the contralateral healthy cerebellum (Fig. 2b) . In fact, the in vivo MR spectrum of the contralateral VOI shows high signals from NAA at 2.0 ppm, Cr at 3.0 ppm, ChoCC at 3.2 ppm, and myo-inositol (Myo) at 3.5 ppm. Lower signals due to NAA at 2.5 ppm and to Glx at 2.3 ppm are also observed. The signal at 3.5 ppm could receive contributions from both Myo and glycine (Gly). Signals at higher frequencies are poorly resolved. ChoCC/Cr metabolite signal intensity ratio is within the range measured for the cerebellar tissue of healthy children, while a reduction of NAA/ChoCC and NAA/Cr ratios is evident (20) (21) (22) . We hypothesized that the reduction of NAA was an expression of mild oedema and neuronal dysfunction in the otherwise normal appearing brain tissue chosen for MRS, an effect in agreement with the high compression exerted by the tumor. A conventional presaturated 1D spectrum, which highlights both lipid and small metabolite contribution, is displayed in panel a. Fig. 3b shows a spectrum obtained using a CPMG spin-echo sequence [90˚-(Ù-180˚-Ù) n ], in order to separate signals according to their different T2 and enhance the resonance of metabolites with respect to those of macromolecules. Fig. 3c represents the diffusion-edited spectrum displaying contributions from mobile lipids and macromolecules.
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The most abundant metabolites can be assigned by comparison with literature data, but a complete assignment requires the acquisition of selected 2D experiments such as COSY, TOCSY and HSQC. The COSY and TOCSY spectra are very informative for the identification of hidden resonances: the COSY spectra enable the coupled proton-proton pairs to be found, whereas the TOCSY spectra permit the identification of 1 H, 1 H connectivities of up to 5 or 6 bonds. 1 H, 13 C HSQC spectra permit the identification of directly bonded carbonproton correlations, making it possible to assign singlets (which do not give correlations in homonuclear COSY and TOCSY spectra), and distinguish signals from different molecules having similar proton chemical shifts, but diverse 13 C signals. These experiments enable a complete and unambiguous identification of the metabolic pattern characterizing the examined tissue. The principal metabolites are labelled in Fig. 4 , and the 1 H and 13 C assignments of the observed pool of metabolites, particularly osmolites, free amino acids and a fraction of mobile lipids, are reported in Table I .
A look at the HR-MAS spectra shows that the spectral detail is much higher than that obtainable in vivo, and that Myo, Tau and phosphorylethanolamine (PE), and a trace of arginine, contribute to the in vivo signal at 3.2 ppm, usually attributed to ChoCC [glycerophosphorylcholine (GPC), phosphorylcholine (PC) and free choline (Cho)]. The H-5 proton signal of Myo at 3.28 ppm (triplet) is detected through the correlation with H-4,6 at 3.63 ppm in the COSY spectrum, and the correlations with other protons of its spin system (4.06, 3.63, and 3.53 ppm) in the TOCSY spectrum (Fig. 5a ). The CH 2 N protons of PE at 3.23 ppm (triplet) are detected in both homonuclear correlation spectra, through a correlation with CH 2 O at 4.00 ppm (a double triplet, which resembles a quartet), which shows a coupling with the phosphorous nucleus. Similarly, the CH 2 N protons of Tau at 3.26 ppm (triplet) are detected through the correlation with CH 2 S at 3.42 ppm (triplet). An estimation of relative contributions of these metabolites to the integral value of signals between 3.32 and 3.15 ppm, usually attributed to the in vivo spectra of ChoCC, can be derived from the evaluation of areas of selected Table I . Continued. c C· probably contributes to the 3.77, 55.2 ppm cross-peak.
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signals (weighted on the basis of the relative proton numbers). This calculation leads to the presence of 20% PE, 18% Tau, 55% PC + Cho, and 7% Myo. The same experiments highlight a contribution from the CH 2 N lysine and CH 2 COO -asparagine signals to the in vivo signal at 3.0 ppm, usually attributed to NCH 3 creatine protons (Fig. 5b) . Creatine participates in 60% of the total area of the region 3.10-2.90 ppm, as deduced by comparison of the integral of the signal at 3.92 ppm (CH 2 protons of creatine). Finally, ex vivo 1 H MRS experiments indicate the presence of alanine (Ala) and lactate (Lac) and the absence of NAA. The absence of NAA in the HR-MAS spectra and presence of only a trace of acetate suggest that the peak at 2.0 ppm in the in vivo spectrum could be principally due to the CH 2 (ß) and CH 2 (Á) signals of glutamate plus glutamine.
A direct comparison between the in vivo and ex vivo MR profiles of medulloblastoma can be made after applying a broadening processing function to the HR-MAS signal which, although implying the loss of a higher degree of information furnished by the HR-MAS spectrum, shows the close correspondence between the two spectra (Fig. 6) , especially when the region of ChoCC and Cr signals is considered. The highest signal is that usually attributed to ChoCC, which we have shown above to receive contributions from a number of other metabolites, accompanied by low intensity peaks due to glutamate plus glutamine at 2.3 and 2.0 ppm, and Cr (plus lysine and asparagine) at 3.0 ppm. More difficult is the comparison between regions at higher frequencies of the two spectra, where signals due to Tau, Myo, Gly and PE are expected. These signals are evident in the ex vivo spectrum, but they are less clear in vivo because of more distortions from the evolution of coupling constants. The estimation of the ratio ChoCC/Cr from the in vivo spectrum (5/1) compares well with that from the HR-MAS spectrum (6.5/1) obtained, considering the regions 3.15-3.32 and 3.10-2.90 ppm. Myo, Tau, Gly and PE have already been reported as significant metabolites from in vitro MRS studies on medulloblastoma (25, 26) . Accordingly, prominent Tau, Gly and PE peaks are easily observed in our ex vivo spectrum (Fig. 4) , and the presence of Tau in in vivo spectra of the medulloblastoma has been reported (27, 28) .
Further considerations can be argued from the analysis of ex vivo MR spectra. Mobile lipids, which are already visible in the standard presaturated 1D spectrum (Fig. 3a) , are further evidenced in the diffusion-edited spectrum (Fig. 3c) by the broad signals at 0.89, 1.30, 3.26 and 5.32 ppm. In particular, the 3.26 ppm resonance, deriving from the trimethylammonium of the choline residue, strongly suggests that phospholipids are present in substantial amounts in the examined medulloblastoma. It is worthwhile to underline the presence of broad signals at 3.02 and 1.72 ppm (which are correlated by the TOCSY experiments also to the 1.48 and 1.91 ppm signals), attributable to lysine in non-negligible amounts and possibly involved in lysyl-phosphatidylglycerols. These findings provide a deeper insight into the lipid composition of brain neoplasms to be pursued. It has been reported that the presence of mobile lipids, both in ex vivo and in vivo MR spectra of brain neoplasms, is correlated to necrosis in the lesions (29, 30) . This spectroscopic datum directly correlates to a morphological aspect of the histopathological assessment. Moreover, Tzika et al reported that in vivo and ex vivo MR spectra of several pediatric brain tumors exhibited substantial levels of lipids, which may be due to apoptosis and/or necrosis (31) . As a consequence, the histological features of apoptosis and necrosis, evidenced in the histological analysis of this medulloblastoma, are reflected by the presence of lipid signals in our ex vivo HR-MAS MR spectra.
In this case report, we have demonstrated that the ex vivo HR-MAS MR spectroscopy can reach a high resolution degree, thus providing a link between in vivo MRS and neuropathological analysis. The present study demonstrates that ex vivo HR-MAS 1 H MRS is able to strongly improve the clinical possibility of in vivo MRS and can be used in conjunction with in vivo spectroscopy for clinical purposes, in which case a large number of samples can be analyzed and histologically classified. 
